CB Therapeutics, Inc.

CIK: 1949369DEIncorporated: 2015-03-20

Current Offering

$25,000
Target Amount
$1,235,000
Maximum Amount
2023-04-30
Deadline

Security Details

Type: Crowd SAFE (Simple Agreement for Future Equity)
Price per share: $1.00
Shares offered: 25,000+

Offering Costs

Cash commission: 6%
At the conclusion of the offering, the issuer shall pay a fee of six percent (6%) of the amount raised ni the offering to the Intermediary.
Equity compensation: 2%
The Intermediary will also receive compensation in the form of securities equal to two percent( 2 % of the total number of the securities sold in the offering.

Financial Reports

Offering via Republic

Offering History

As of 2023-02-27
Raising $25,000 -$1,235,000 via 25,000+ shares of crowd SAFE (Simple Agreement for Future Equity) at $1.00 per share
Deadline: 2023-04-30
Filing date2023-02-27
Current employees18
Act received most recent fiscal year$14,066
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$1,810,709
Cash equi prior fiscal year$13,453
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$188,555
Long term debt prior fiscal year$730,988
Net income most recent fiscal year-$1,772,158.00
Net income prior fiscal year-$2,278,343.00
Revenue most recent fiscal year$2,014,066
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$287,110
Short term debt prior fiscal year$677,795
Tax paid most recent fiscal year$3,017
Tax paid prior fiscal year$1,600
Total asset most recent fiscal year$3,722,376
Total asset prior fiscal year$910,015

Company Information

Corporation
DE
2015-03-20

Latest Metrics

Employees18
Total Assets$3,722,376
Cash on Hand$1,810,709
Revenues$2,014,066
Net Income-$1,772,158.00

Crowdfunding Portals

This company is raising funds through this portal